Abstract
Background: An early age at menarche, a short menstrual cycle length, and a high age at first full term pregnancy or nulliparity are known risk factors for breast cancer. These risk factors have previously been reported to differ between breast cancer patients with and without a family history of breast cancer and also between breast cancer patients and controls.
Methods: Self-administered questionnaires were filled out by 95 women belonging to 24 families with known BRCA1 mutations, 16 women belonging to nine families with known BRCA2 mutations, and 95 women belonging to 65 families with hereditary breast cancer where no BRCA1 or BRCA2 mutations could be detected. Thirty-nine women were BRCA1 mutation carriers and 56 women were BRCA1 negative, 11 women were BRCA2 carriers and five BRCA2 negative. All women were born between 1905 and 1979.
Results: Age at menarche, physiological menstrual cycle length at age 30 or at current age in younger women (when not using oral contraceptives), age at first full term pregnancy, and nulliparity did not significantly differ between BRCA1 mutation carriers and BRCA1 negative women. Too few women were BRCA2 negative to serve as a control group. BRCA2 mutation carriers were therefore compared with BRCA1 negative and BRCA2 negative women. None of the above reproductive factors did significantly differ between BRCA2 mutation carriers and from BRCA1 and BRCA2 families. Women from non-BRCA1/BRCA2 hereditary breast cancer families had a higher age at menarche, but this was no longer significant after adjustment for other factors in a multivariate model.
Conclusion: Our results suggest that reproductive risk factors of breast cancer are not related to BRCA1 or BRCA2 carrier status. There was also no indication that these factors differ in carriers of unknown susceptibility genes compared with non-carriers from BRCA1 and BRCA2 families.
Similar content being viewed by others
References
Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(4988): 1684–1689, 1990
Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, et al.: Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338(8759): 82–83, 1991
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshmann K, Tavtigian S, et al.: A strong candidate for breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182): 66–71, 1994
Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al.: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273(7): 535–541, 1995
Håkansson S, Johannsson O, Johansson U, Gerdes A-M, Holmberg E, Dahl N, et al.: Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am J Hum Genet 60(5): 1068–1078, 1997
Johannsson O, Ostermeyer E, Håkansson S, Friedman L, Johansson U, Sellberg G, et al.: Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Hum Genet 58(3): 441–450, 1996
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al.: Localization of breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265(5181): 2088–2090, 1994
Streuwing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al.: The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among ashkenazi jews. N Engl J Med 336(20): 1401–1408, 1997
Szabo CI, Wagner LA, Francisco LV, Roach JC, Argonza R, King MC, et al.: Humane, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 5(9): 1289–1298, 1996
Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH: BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12(2): 191–194, 1996
Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, et al.: The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85(7): 1009–1023, 1996
Liu C, Flesken Nikitin A, Li S, Zeng Y, Lee W: Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10(14): 1835-1843, 1996
Suzuki A, Luis de la Pompa J, Hakem R, Elia A, Yoshida R, Mo R, et al.: BRCA2 is required for embryonic cellular proliferation in the mouse. Genes and development 11: 1242–1252, 1997
Jernström H, Johannsson O, Borg Å, Ivarsson H, Olsson H: BRCA1-positive patients are small for gestational age compared with their unaffected relatives. Eur J Cancer 34(3): 368–371, 1998
Jernström H, Johannsson O, Borg Å, Olsson H: Do BRCA1 mutations affect the ability to breast feed? Significantly shorter length of breast feeding among BRCA1 mutation carriers compared with their unaffected relatives. Breast 7: 320–324, 1998
Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 15(l): 36–47, 1993
Olsson H, Landin-Olsson M, Kristoffersson U, Ranstam J: Risk factors of breast cancer in relation to a family history of breast cancer in Southern Sweden. In: Müller HJ and Weber W (eds), Familial Cancer. Basel, Karger, 1985, pp. 34–35
Magnusson C, Colditz G, Rosner B, Bergström R, Persson I: Association of family history and other risk factors with breast cancer risk. Cancer Causes Control 9(3): 259–267, 1998
Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, et al.: Familial history and the risk of breast cancer. JAMA 253(13): 1908–1913, 1985
Anderson DE, Badzioch MD: Combined effect of family history and reproductive factors. Cancer 63(2): 349–353, 1989
Lynch H, Albano W, Layton M, Kimberling WJ, Lynch JF: Breast cancer, genetics and age at first pregnancy. J Med Genet 21(2): 96–98, 1984
Parazzini F, La Vecchia C, Negri E, Franchesci S, Bocciolone L: Menstrual and reproductive factors and breast cancer in women with family history of the disease. Int J Cancer 51(5): 677–681, 1992
Negri E, La Vecchia C, Bruzzi P, Dardanoni G, Decarli A, Palli D, et al.: Risk factors for breast cancer: pooled results from three Italian case-control studies. Am J Epidemiol 128(6): 1207–1215, 1988
Andrieu N, Clavel F, Auquier A, Le MG, Gairard B, Piana L, et al.: Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol 46(9): 973–980, 1993
Dupont WD, Page DL: Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 125(5): 769–779, 1987
Sellers TA, Kushi LH, Potter JD, Kaye SA, Nelson CL, McGovern PG, et al.: Effect of family histoiy, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 326(20): 1323–1329, 1992
Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, et al.: Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64(6): 394–398, 1995
Johannsson O, Loman N, Borg Å, Olsson H: Pregnancyassociated breast cancer in BRCAI and BRCA2 germline mutation carriers [research letter]. Lancet 352(9137): 1359–1360, 1998
Loman N, Johannsson O, Bendahl P-O, Borg Å, Fernö M, Olsson H: Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83: 310–319, 1998
Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, Leder P: Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9(21): 2712–2722, 1995
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, et al.: The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11(1): 17–26, 1995
Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, et al.: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth & Differentiation 7(6): 711–715, 1996
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, et al.: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88(2): 265–275, 1997
Rights and permissions
About this article
Cite this article
Jernström, H.C., Johannsson, O.T., Loman, N. et al. Reproductive factors in hereditary breast cancer. Breast Cancer Res Treat 58, 293–299 (1999). https://doi.org/10.1023/A:1006375123262
Issue Date:
DOI: https://doi.org/10.1023/A:1006375123262